MedTrace Logo

Atrial Fibrillation and By-pass Surgery

NCT01955759 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2013-12-17

No results posted yet for this study

Summary

The aim of the study is to evaluate whether combined therapy with beta-blocker, amiodarone and statine is better than beta-blocker alone for the prevention of atrial fibrillation after coronary by-pass surgery.

Conditions

  • Patients With Coronary Artery Disease Scheduled for by Pass Surgery

Interventions

DRUG

Amiodarone tab 200 mg x 3

starting 7 days before coronary by-pass surgery per os 200 mg. x 3 tab, followed by 200 mg x 2 tab per os starting on the second postoperative day untill discharge

DRUG

rosuvastatin 20 mg tab x1

starting 7 days before coronary by-pass surgery

DRUG

beta blockers Bisoprolol in adjusted dose

starting 7 days befoe coronary by-pass surgery

Sponsors & Collaborators

  • Heart Center BH Tuzla

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • Bosnia and Herzegovina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01955759 on ClinicalTrials.gov